Prinston Inc Company Profile
What is the competitive landscape for PRINSTON INC
PRINSTON INC has ninety-three approved drugs.
There are three tentative approvals on PRINSTON INC drugs.
Summary for Prinston Inc
| US Patents: | 0 |
| Tradenames: | 82 |
| Ingredients: | 81 |
| NDAs: | 93 |
Drugs and US Patents for Prinston Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | HYDROXYZINE HYDROCHLORIDE | hydroxyzine hydrochloride | TABLET;ORAL | 040580-002 | May 27, 2005 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 208781-003 | Apr 26, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | LISINOPRIL | lisinopril | TABLET;ORAL | 075743-004 | Jul 1, 2002 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | PAROXETINE | paroxetine hydrochloride | TABLET;ORAL | 203854-001 | Oct 31, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | NEBIVOLOL HYDROCHLORIDE | nebivolol hydrochloride | TABLET;ORAL | 212682-003 | Apr 7, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | TADALAFIL | tadalafil | TABLET;ORAL | 210609-001 | Aug 11, 2022 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
